- Home
- SDGR
SDGR
Schrodinger Inc.
as 11-15-2024 3:39pm EST
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.3B | IPO Year: | 2020 |
| Target Price: | $32.90 | AVG Volume (30 days): | 910.2K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.45 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.67 - $38.00 | Next Earning Date: | 11-12-2024 |
| Revenue: | $193,348,000 | Revenue Growth: | -3.03% |
| Revenue Growth (this year): | -1.22% | Revenue Growth (next year): | 24.24% |
Stock Insider Trading Activity of Schrodinger Inc. (SDGR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dugan Margaret | SDGR | Chief Medical Officer | Oct 15 '24 | Sell | $17.78 | 1,531 | $27,225.77 | 13,469 |
Latest Schrodinger Inc. News
SDGR Breaking Stock News: Dive into SDGR Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
TipRanks
4 days ago
Schrodinger announces expanded license agreement with Novartis
GuruFocus.com
4 days ago
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
Thomson Reuters StreetEvents
4 days ago
Q3 2024 Schrodinger Inc Earnings Call
Argus Research
4 days ago
SDGR: Raising target price to $18.00
Benzinga
5 days ago
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Zacks
5 days ago
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates
Business Wire
5 days ago
Schrödinger Reports Third Quarter 2024 Financial Results
Compare SDGR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SDGR Schrodinger Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.